<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04333992</url>
  </required_header>
  <id_info>
    <org_study_id>KNUH 2016-12-009-001</org_study_id>
    <nct_id>NCT04333992</nct_id>
  </id_info>
  <brief_title>Propofol Versus Sevoflurane on Acute Postoperative Pain</brief_title>
  <official_title>A Comparison of Propofol-remifentanil Versus Sevoflurane-remifentanil: the Effect on Acute Postoperative Pain After Total Shoulder Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yeungnam University College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yeungnam University College of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was performed to compare the acute postoperative pain intensity and opioid
      consumption after total shoulder arthroplasty between propofol-remifentanil and
      sevoflurane-remifentanil anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After approval of the Institutional Review Board and written informed consent, 48 patients,
      aged 18-65 years for shoulder arthroplasty were enrolled in this prospective, randomized,
      double-blinded study.

      Patients were assigned to one of two groups : group PR, the propofol-remifentanil group; and
      group SR, the sevoflurane-remifentanil group.

      In the group PR, anesthetic induction was achieved with an initial target concentration of
      propofol 4 ㎍/mL and remifentanil 3-4 ng/mL using target controlled infusion (TCI) devices and
      rocuronium 0.8 mg/kg. After intubation, anesthesia was maintained with fixed target
      concentration of propofol 2-4 ㎍/mL and remifentanil 2-3 ng/mL to keep acceptable hemodynamic
      response and bispectral index (BIS) values 40-60.

      In the group SR, anesthetic induction was achieved with thiopental 5 mg/kg and initial target
      concentration of remifentanil 3-4 ng/mL using TCI and rocuronium 0.8 mg/kg. Anesthesia was
      maintained with 1.5-2.5% end-tidal concentration sevoflurane in 50% oxygen with air and
      remifentanil 2-3 ng/mL was continuously infused adjusting to maintain an acceptable
      hemodynamics and BIS values 40-60.

      The administration of propofol or sevoflurane with remifentanil was stopped at the surgery
      ended.

      Postoperative pain intensity was assessed using a numerical rating scale (NRS: 0; no pain,
      10; worst pain) at the 30 min, 2, 6, 12, 24 h. Also, the patient-controlled analgesia (PCA)
      was infused immediately after post anesthetic care unit arrival. The PCA device was set to
      deliver 0.38 ㎍/kg/h of fentanyl as a basal infusion rate and 20 ㎍ on demand with a 15 min
      lockout time. The total PCA volume, number of patients to need rescue analgesics was
      recorded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Actual">January 1, 2018</completion_date>
  <primary_completion_date type="Actual">December 12, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain intensity</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>numerical rating scale 0-10 (NRS: 0; no pain, 10; worst pain)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative opioid consumption</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>total patient controlled anesthesia (PCA) volume</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>propofol-remifentanil group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Anesthetic induction was achieved with an initial target concentration of propofol 4 ㎍/mL and remifentanil 3-4 ng/mL.
Anesthesia was maintained with a fixed target concentration of propofol 2-4 ㎍/mL and remifentanil 2-3 ng/mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sevoflurane-remifentanil group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Anesthetic induction was achieved with thiopental 5 mg/kg and initial target concentration of remifentanil 3-4 ng/mL.
Anesthesia was maintained with 1.5-2.5% end-tidal concentration sevoflurane in 50% oxygen with air and remifentanil 2-3 ng/mL</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol and remifentanil</intervention_name>
    <description>intravenous propofol and remifentanil using target-controlled infusion (TCI) devices</description>
    <arm_group_label>propofol-remifentanil group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sevoflurane and remifentanil</intervention_name>
    <description>inhalator sevoflurane and remifentanil using target-controlled infusion (TCI) devices</description>
    <arm_group_label>sevoflurane-remifentanil group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists (ASA) I or II and aged 18-65 years for total
             shoulder arthroplasty

        Exclusion Criteria:

          -  Use of routinely using analgesics, history of neurologic or psychologic disease, body
             mass index more than 35 kg/m2, and intake of any sedatives or analgesics within 24 h
             before surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Eun kyung Choi</name>
      <address>
        <city>Daegu</city>
        <state>Korea (the Republic Of)</state>
        <zip>41944</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 1, 2020</study_first_submitted>
  <study_first_submitted_qc>April 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2020</study_first_posted>
  <last_update_submitted>April 1, 2020</last_update_submitted>
  <last_update_submitted_qc>April 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yeungnam University College of Medicine</investigator_affiliation>
    <investigator_full_name>Eun Kyung Choi</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>propofol</keyword>
  <keyword>sevoflurane</keyword>
  <keyword>anesthesia</keyword>
  <keyword>shoulder arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

